https://daunorubicininhibitor.....com/long-term-use-of
The present study involved 22 newborns diagnosed with ductal-dependent congenital heart disease (CCHD) and receiving PGE1 infusions for a duration exceeding one week. The PGE1 infusion prompted ultrasonographic evaluations of pyloric thickness and length, a week later and initially. ClinicalTrials.gov received the protocol's registration information. The clinical trial NCT04496050. The study population comprised 22 neonates, with a mean gestational a
Like
Comment
Share
